Cargando…
Comprehensive analysis of pan‐cancer reveals potential of ASF1B as a prognostic and immunological biomarker
BACKGROUND: Anti‐silencing function 1 (ASF1) is a conserved histone H3–H4 chaperone protein. ASF1B, a paralog of ASF1, acts by promoting cell proliferation and influencing cell cycle progression. Although there is some evidence demonstrating that ASF1B plays a key role in the development, progressio...
Autores principales: | Hu, Xinyao, Zhu, Hua, Zhang, Xiaoyu, He, Xiaoqin, Xu, Ximing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495294/ https://www.ncbi.nlm.nih.gov/pubmed/34472711 http://dx.doi.org/10.1002/cam4.4203 |
Ejemplares similares
-
A five‐gene signature is a prognostic biomarker in pan‐cancer and related with immunologically associated extracellular matrix
por: Yu, Chunlai, et al.
Publicado: (2021) -
The prognostic and immunological role of MYB: from bladder cancer validation to pan-cancer analysis
por: Cui, Xiaobo, et al.
Publicado: (2023) -
The comprehensive analysis of the prognostic and functional role of N-terminal methyltransferases 1 in pan-cancer
por: Tan, Lifan, et al.
Publicado: (2023) -
Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment
por: Zhu, Zhipeng, et al.
Publicado: (2021) -
Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer
por: Song, Xiang, et al.
Publicado: (2019)